相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies
Marie R. G. Kopp et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2023)
ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation
Brennan Abanades et al.
BIOINFORMATICS (2022)
Nucleation in Protein Aggregation in Biotherapeutic Development: A look into the Heart of the Event
Tapan K. Das et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy
Surbhi Gupta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells
Alexandra Roesch et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics
Rahul Khetan et al.
MABS (2022)
SAbDab in the age of biotherapeutics: updates including SAbDab-nano, the nanobody structure tracker
Constantin Schneider et al.
NUCLEIC ACIDS RESEARCH (2022)
Antibody display technologies: selecting the cream of the crop
Bernhard Valldorf et al.
BIOLOGICAL CHEMISTRY (2022)
Miniaturized Forced Degradation of Therapeutic Proteins and ADCs by Agitation-Induced Aggregation Using Orbital Shaking of Microplates
Florian Johann et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Combining Machine Learning and Backgrounded Membrane Imaging: A Case Study in Comparing and Classifying Different Types of Biopharmaceutically Relevant Particles
Christopher P. Calderon et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging
Markela Ibo Murphy et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Reduction of therapeutic antibody self-association using yeast-display selections and machine learning
Emily K. Makowski et al.
MABS (2022)
Designing antibodies as therapeutics
Paul J. Carter et al.
CELL (2022)
Non-specificity as the sticky problem in therapeutic antibody development
Hannes Ausserwoger et al.
NATURE REVIEWS CHEMISTRY (2022)
Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space
Emily K. Makowski et al.
NATURE COMMUNICATIONS (2022)
NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning
Tomer Cohen et al.
FRONTIERS IN IMMUNOLOGY (2022)
Understanding opalescence measurements of biologics-A comparison study of methods, standards, and molecules
Patrick Kunz et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs
Andre A. R. Teixeira et al.
MABS (2022)
Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
Ian Wilkinson et al.
MABS (2022)
Monoclonal antibody therapies for COVID-19: lessons learned and implications for the development of future products
Brian Kelley et al.
CURRENT OPINION IN BIOTECHNOLOGY (2022)
Computational counterselection identifies nonspecific therapeutic biologic candidates
Sachit Dinesh Saksena et al.
CELL REPORTS METHODS (2022)
An antibody scanning method for the detection of α-synuclein oligomers in the serum of Parkinson's disease patients
Klara Kulenkampff et al.
CHEMICAL SCIENCE (2022)
Deciphering the language of antibodies using self-supervised learning
Jinwoo Leem et al.
PATTERNS (2022)
Simultaneous Maturation of Single Chain Antibody Stability and Affinity by CHO Cell Display
Ruiqi Luo et al.
BIOENGINEERING-BASEL (2022)
Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents
Maxime Lecerf et al.
ANTIBODIES (2022)
Antibody structure prediction using interpretable deep learning
Jeffrey A. Ruffolo et al.
PATTERNS (2022)
Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation
Harini Narayanan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
Disulfide-compatible phage-assisted continuous evolution in the periplasmic space
Mary S. Morrison et al.
NATURE COMMUNICATIONS (2021)
Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies
Carolin Berner et al.
MOLECULAR PHARMACEUTICS (2021)
FDA approves 100th monoclonal antibody product
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Animal Immunization, in Vitro Display Technologies, and Machine Learning for Antibody Discovery
Andreas H. Laustsen et al.
TRENDS IN BIOTECHNOLOGY (2021)
Protein design and variant prediction using autoregressive generative models
Jung-Eun Shin et al.
NATURE COMMUNICATIONS (2021)
Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning
Derek M. Mason et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities
Maxime Lecerf et al.
COMMUNICATIONS BIOLOGY (2021)
Reversibility and irreversibility in the temperature denaturation of monoclonal antibodies
Arne Schon et al.
ANALYTICAL BIOCHEMISTRY (2021)
Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties
Charles G. Starr et al.
MOLECULAR PHARMACEUTICS (2021)
Design of Biopharmaceutical Formulations Accelerated by Machine Learning
Harini Narayanan et al.
MOLECULAR PHARMACEUTICS (2021)
Rapid generation of potent antibodies by autonomous hypermutation in yeast
Alon Wellner et al.
NATURE CHEMICAL BIOLOGY (2021)
Intrinsic physicochemical profile of marketed antibody-based biotherapeutics
Lucky Ahmed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Bispecific antibodies
Ulrich Brinkmann et al.
SCIENCE (2021)
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
Andre Azevedo Reis Teixeira et al.
MABS (2021)
Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns
Orla Cunningham et al.
MABS (2021)
Computational maturation of a single-domain antibody against Aβ42 aggregation
Jiacheng Lin et al.
CHEMICAL SCIENCE (2021)
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods
Emily K. Makowski et al.
MABS (2021)
Structure-based charge calculations for predicting isoelectric point, viscosity, clearance, and profiling antibody therapeutics
Nels Thorsteinson et al.
MABS (2021)
Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development
Constanze Helbig et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle
Roman Mathaes et al.
AAPS JOURNAL (2020)
Antibody complementarity determining region design using high-capacity machine learning
Ge Liu et al.
BIOINFORMATICS (2020)
Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability
Ruben Waelchli et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Taking Subvisible Particle Quantitation to the Limit: Uncertainties and Statistical Challenges With Ophthalmic Products for Intravitreal Injection
Marina Githlke et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization
Lorenzo Gentiluomo et al.
MOLECULAR PHARMACEUTICS (2020)
A Nanoparticle-Based Assay To Evaluate Surface-Induced Antibody Instability
Marie R. G. Kopp et al.
MOLECULAR PHARMACEUTICS (2020)
An in vivo platform to select and evolve aggregation-resistant proteins
Jessica S. Ebo et al.
NATURE COMMUNICATIONS (2020)
Modulated Scanning Fluorimetry Can Quickly Assess Thermal Protein Unfolding Reversibility in Microvolume Samples
Hristo L. Svilenov et al.
MOLECULAR PHARMACEUTICS (2020)
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity
Yulei Zhang et al.
MOLECULAR PHARMACEUTICS (2020)
Developing therapeutic monoclonal antibodies at pandemic pace
Brian Kelley
NATURE BIOTECHNOLOGY (2020)
A single molecular descriptor to predict solution behavior of therapeutic antibodies
Jonathan S. Kingsbury et al.
SCIENCE ADVANCES (2020)
Formulations That Suppress Aggregation During Long-Term Storage of a Bispecific Antibody are Characterized by High Refoldability and Colloidal Stability
Hristo L. Svilenov et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
Francesco A. Aprile et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Toward Drug-Like Multispecific Antibodies by Design
Manali S. Sawant et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices
Stefan Dengl et al.
NATURE COMMUNICATIONS (2020)
Structure, Function, and Therapeutic Use of IgM Antibodies
Bruce A. Keyt et al.
ANTIBODIES (2020)
An accelerated surface-mediated stress assay of antibody instability for developability studies
Marie R. G. Kopp et al.
MABS (2020)
Development of therapeutic antibodies for the treatment of diseases
Ruei-Min Lu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
Beyond affinity: selection of antibody variants with optimal biophysical properties and reduced immunogenicity from mammalian display libraries
Michael R. Dyson et al.
MABS (2020)
Predicting Antibody Developability Profiles Through Early Stage Discovery Screening
Marc Bailly et al.
MABS (2020)
Recovery, overloading, and protein interactions in asymmetrical flow field-flow fractionation
Maria Marioli et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Five computational developability guidelines for therapeutic antibody profiling
Matthew I. J. Raybould et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues
Nazli Eda Kaleli et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2019)
The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage
Hristo Svilenov et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing
Kothai Parthiban et al.
MABS (2019)
Affinity Maturation Enhances Antibody Specificity but Compromises Conformational Stability
Laila Shehata et al.
CELL REPORTS (2019)
Selecting and engineering monoclonal antibodies with drug-like specificity
Charles G. Starr et al.
CURRENT OPINION IN BIOTECHNOLOGY (2019)
Deamidation and isomerization liability analysis of 131 clinical-stage antibodies
Xiaojun Lu et al.
MABS (2019)
Attentive Cross-Modal Paratope Prediction
Andreea Deac et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2019)
Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility
Lilia A. Rabia et al.
BIOCHEMICAL ENGINEERING JOURNAL (2018)
Parapred: antibody paratope prediction using convolutional and recurrent neural networks
Edgar Liberis et al.
BIOINFORMATICS (2018)
Computational design of antibodies
Sharon Fischman et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Notorious but not understood: How liquid-air interfacial stress triggers protein aggregation
Ellen Koepf et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries
Ryan L. Kelly et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Microfluidic Approaches for the Characterization of Therapeutic Proteins
Marie R. G. Kopp et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Postproduction Handling and Administration of Protein Pharmaceuticals and Potential Instability Issues
M. Reza Nejadnik et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
High-throughput antibody engineering in mammalian cells by CRISPR/Cas9-mediated homology-directed mutagenesis
Derek M. Mason et al.
NUCLEIC ACIDS RESEARCH (2018)
The structural basis of nanobody unfolding reversibility and thermoresistance
Patrick Kunz et al.
SCIENTIFIC REPORTS (2018)
A New Approach to Study the Physical Stability of Monoclonal Antibody Formulations-Dilution From a Denaturant
Hristo Svilenov et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Combining Structural Aggregation Propensity and Stability Predictions To Redesign Protein Solubility
Marcos Gil-Garcia et al.
MOLECULAR PHARMACEUTICS (2018)
Continuous directed evolution of proteins with improved soluble expression
Tina Wang et al.
NATURE CHEMICAL BIOLOGY (2018)
Rational optimization of a monoclonal antibody for simultaneous improvements in its solution properties and biological activity
Sandeep Kumar et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2018)
Net charge of antibody complementarity-determining regions is a key predictor of specificity
Lilia A. Rabia et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2018)
Computational Design of Epitope-Specific Functional Antibodies
Guy Nimrod et al.
CELL REPORTS (2018)
Computational tools help improve protein stability but with a solubility tradeoff
Aron Broom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs
Kathryn E. Tiller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Prediction and Reduction of the Aggregation of Monoclonal Antibodies
Rob van der Kant et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities
Neal Whitaker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Nonspecificity in a nonimmune human scFv repertoire
Ryan L. Kelly et al.
MABS (2017)
The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Biophysical properties of the clinical-stage antibody landscape
Tushar Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Principles for computational design of binding antibodies
Dror Baran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Facile affinity Maturation of antibody Variable Domains Using natural Diversity Mutagenesis
Kathryn E. Tiller et al.
FRONTIERS IN IMMUNOLOGY (2017)
Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability
Mark C. Julian et al.
SCIENTIFIC REPORTS (2017)
De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide
Kevin C. Entzminger et al.
SCIENTIFIC REPORTS (2017)
Ultrafiltration Behavior of Monoclonal Antibodies and Fc-Fusion Proteins: Effects of Physical Properties
Youngbin Baek et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
Computational de novo design of antibodies binding to a peptide with high affinity
Venkata Giridhar Poosarla et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
An in vivo platform for identifying inhibitors of protein aggregation
Janet C. Saunders et al.
NATURE CHEMICAL BIOLOGY (2016)
Conformational stability and self-association equilibrium in biologics
Benjamin R. Clarkson et al.
DRUG DISCOVERY TODAY (2016)
Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments
Parisa Moghaddam-Taaheri et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold
Alice R. Mazzer et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
Pietro Sormanni et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Examination of Thermal Unfolding and Aggregation Profiles of a Series of Developable Therapeutic Monoclonal Antibodies
Mark L. Brader et al.
MOLECULAR PHARMACEUTICS (2015)
Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins
Pietro Sormanni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy
Jiemin Wu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
Optimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system
T. Noelle Lombana et al.
SCIENTIFIC REPORTS (2015)
ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade
Karen Silence et al.
MABS (2014)
High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy
Yuqi Liu et al.
MABS (2014)
Optimizing recombinant antibodies for intracellular function using hitchhiker-mediated survival selection
Dujduan Waraho-Zhmayev et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Therapeutic protein aggregation: mechanisms, design, and control
Christopher J. Roberts
TRENDS IN BIOTECHNOLOGY (2014)
Non-Arrhenius Protein Aggregation
Wei Wang et al.
AAPS JOURNAL (2013)
Rapid Analysis of Antibody Self-Association in Complex Mixtures Using Immunogold Conjugates
Shantanu V. Sule et al.
MOLECULAR PHARMACEUTICS (2013)
Rapid optimization and prototyping for therapeutic antibody-like molecules
Lihui Xu et al.
MABS (2013)
Improving biophysical properties of a bispecific antibody scaffold to aid developability Quality by molecular design
Thomas Spreter Von Kreudenstein et al.
MABS (2013)
Aggregation Mechanism of an IgG2 and two IgG1 Monoclonal Antibodies at low pH: From Oligomers to Larger Aggregates
Paolo Arosio et al.
PHARMACEUTICAL RESEARCH (2013)
Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool
Yingda Xu et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Directed evolution of proteins for increased stability and expression using yeast display
Michael W. Traxlmayr et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Directed evolution of stabilized IgG1-Fc scaffolds by application of strong heat shock to libraries displayed on yeast
Michael W. Traxlmayr et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
Developability index: A rapid in silico tool for the screening of antibody aggregation propensity
Timothy M. Lauer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
General strategy for the generation of human antibody variable domains with increased aggregation resistance
Kip Dudgeon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation
Dirk Ponsel et al.
MOLECULES (2011)
A system for the continuous directed evolution of biomolecules
Kevin M. Esvelt et al.
NATURE (2011)
Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2010)
Stability of Protein Pharmaceuticals: An Update
Mark Cornell Manning et al.
PHARMACEUTICAL RESEARCH (2010)
Thermodynamically stable aggregation-resistant antibody domains through directed evolution
Kristoffer Famm et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering
Ki Jun Jeong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Markedly increased vitamin B12 concentrations attributable to IgG-IgM-vitamin B12 immune complexes
Raffick A. R. Bowen et al.
CLINICAL CHEMISTRY (2006)
Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G
JD Dimitrov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The FoldX web server: an online force field
J Schymkowitz et al.
NUCLEIC ACIDS RESEARCH (2005)
Autoantibodies unmasked by redox reactions
JA McIntyre et al.
JOURNAL OF AUTOIMMUNITY (2005)
Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies
JGS Ho et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Aggregation-resistant domain antibodies selected on phage by heat denaturation
L Jespers et al.
NATURE BIOTECHNOLOGY (2004)
The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics
W Fraunhofer et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
The appearance and disappearance of anti phospholipid autoantibodies subsequent to oxidation-reduction reactions
JA McIntyre
THROMBOSIS RESEARCH (2004)
Directed evolution of a stable scaffold for T-cell receptor engineering
EV Shusta et al.
NATURE BIOTECHNOLOGY (2000)